J1452 — Injection, fomivirsen sodium, intraocular, 1.65 mg
J1452 is a HCPCS Level II code for injection, fomivirsen sodium, intraocular, 1.65 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J1452 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1452
- Long descriptor
- Injection, fomivirsen sodium, intraocular, 1.65 mg
- Short descriptor
- Intraocular fomivirsen na
- Added
- January 1, 2001
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1452
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1452 is not quite right, the correct code is very often within a few positions of it.
- J1444Injection, ferric pyrophosphate citrate powder, 0.1 mg of ironterminated
- J1445Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of ironterminated
- J1446Injection, tbo-filgrastim, 5 microgramsterminated
- J1447Injection, tbo-filgrastim, 1 microgram
- J1448Injection, trilaciclib, 1mg
- J1449Injection, eflapegrastim-xnst, 0.1 mg
- J1450Injection fluconazole, 200 mg
- J1451Injection, fomepizole, 15 mg
- J1453Injection, fosaprepitant, 1 mg
- J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1455Injection, foscarnet sodium, per 1000 mg
- J1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457Injection, gallium nitrate, 1 mgterminated
- J1458Injection, galsulfase, 1 mg
- J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460Injection, gamma globulin, intramuscular, 1 cc
Questions about J1452
What is HCPCS code J1452?
J1452 is a HCPCS Level II code for injection, fomivirsen sodium, intraocular, 1.65 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1452?
The CMS HCPCS file marks J1452 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J1452 still valid?
No. J1452 was terminated on December 31, 2025 and should not be used on new claims.